Assessment of the role of WIF-1 in the genesis of ischemic heart disease

Cover Page


Cite item

Full Text

Abstract

Coronary heart disease poses one of the most serious threats to human health resulting in enormous physical and economic losses worldwide. WNT signaling pathways play an important role in cardiogenesis both in embryogenesis and cardiac repair after previous ischemic attacks that motivated to conduct this study.
The aim of the study was to examine features of WIF-1 production in patients with coronary heart disease. There were enrolled 60 patients with a clinically verified and diagnosed coronary artery disease. WIF-1 serum concentration was measured by using enzyme-linked immunosorbent assay presenting data as absolute numbers (n, %) or medians, 1 and 3 quartiles – Me (Q0.25-Q0.75). Analyzing study data showed that WIF-1 serum concentration in patients with myocardial infarction was 2890 (1700-3337.5) pg/ml being by 7.97-fold higher than that one in healthy individuals (p <0.001), in agreement with previous studies. Moreover, in patients with angina pectoris WIF-1 serum level comprised 2170 (1493-2650) pg/ml, exceeding that one in healthy individuals by 6.14-fold (p < 0.001). Thus, the data obtained regarding changes in serum WNT-inhibiting factor-1 concentration in patients with coronary heart disease expand our understanding about an impact from affected WNT-signaling pathway components in pathogenesis of inflammatory process during hypoxic injuries.

About the authors

M. O. Plotnikova

I. Turgenev Oryol State University

Author for correspondence.
Email: ekb-lem@mail.ru

Plotnikova Maria O. - Senior Lecturer, Department of Immunology and Specialized Clinical Disciplines

302026, Oryol, Komsomolskaya str., 95

Phone: 7 (905) 802-15-39

Russian Federation

I. A. Snimshchikova

I. Turgenev Oryol State University

Email: fake@neicon.ru

PhD, MD (Medicine), Professor, Head, Department of Immunology and Specialized Clinical Disciplines, Director of Medical Institute

Oryol

Russian Federation

I. A. Afoninа

I. Turgenev Oryol State University

Email: fake@neicon.ru

PhD (Medicine), Associate Professor, Department of Immunology and Specialized Clinical Disciplines

Oryol

Russian Federation

A. S. Kulakova

Bryansk Regional Hospital No. 1

Email: fake@neicon.ru

Gastroenterologist

Bryansk

Russian Federation

References

  1. Плотникова М.О., Снимщикова И.А., Афонина И.А., Самойлова А.В., Кулакова А.С. Оценка показателей морфогенных белков WNT-сигнального пути (склеростина и β-катенина) у пациентов с ишемической болезнью сердца // Медико-фармацевтический журнал «Пульс», 2020. Т. 22, № 4. C. 88-94. [Plotnikova M.O., Snimshchikova I.A., Afonina I.A., Samoylova A.V., Kulakova A.S. Estimation of indicators of morphogenic proteins of wnt-signal way (sclerostin and β-catenin) in patients with coronary heart disease. Mediko-farmatsevticheskiy zhurnal “Puls” = Medical and Pharmaceutical Journal “Pulse” 2020, Vol. 22, no. 4, pp. 88-94. (In Russ.)]
  2. Bassat E., Mutlak Y.E., Genzelinakh A., Shadrin I.Y., Baruch Umansky K., Yifa O., Kain D., Rajchman D., Leach J., Riabov Bassat D., Udi Y., Sarig R., Sagi I., Martin J.F., Bursac N., Cohen S., Tzahor E. The extracellular matrix protein agrin promotes heart regeneration in mice. Nature, 2017, Vol. 547, no. 7662, pp. 179-184.
  3. Bastakoty D., Saraswati S., Joshi P., Atkinson J., Feoktistov I., Liu J., Harris J.L., Young P.P. Temporary, systemic Inhibition of the WNT/β-Catenin pathway promotes regenerative cardiac repair following myocardial infarct. Cell. Stem. Cells Regen. Med., 2016. Vol. 2, no. 2, 10. doi: 10.16966/2472-6990.111.
  4. Carney R.M., Freedland K.E. Depression and coronary heart disease. Nat. Rev. Cardiol., 2017, Vol. 14, pp. 145-155.
  5. Daskalopoulos E.P., Hermans K.C.M., Janssen B.J.A., Blankesteijn W.M. Targeting the Wnt/frizzled signaling pathway after myocardial infarction: A new tool in the therapeutic toolbox? Trends Cardiovasc. Med., 2013, Vol. 23, no. 4, pp. 121-127.
  6. Duchartre Y., Kim Y.M., Kahn M. The Wnt signaling pathway in cancer. Crit. Rev. Oncol. Hematol., 2016, Vol. 99, pp. 141-149.
  7. Eisenberg L.M., Eisenberg C.A. Wnt signal transduction and the formation of the myocardium. Dev. Biol., 200, Vol. 293, pp. 305-315.
  8. Ezekowitz J.A., O’Meara E., McDonald M.A., Abrams H., Chan M., Ducharme A., Giannetti N., Grzeslo A., Hamilton P. G., Heckman G.A., Howlett J.G., Koshman Sh.L, Lepage S., McKelvie R.S., Moe G.W., Rajda M., Swiggum E., Virani S.A., Zieroth Sh., Al-Hesayen A., Cohen-Solal A., d’Astous M., De S., Estrella-Holder E., Fremes S., Green L., Haddad H., Harkness K., Hernandez A.F., Kouz S., LeBlanc M.H., Masoudi F.A., Ross H.J., Roussin A., Sussex B. Comprehensive update of the Canadian Cardiovascular Society Guidelines for the management of heart failure. Can. J. Cardiol., 2017, Vol. 33, 1342. doi: 0.1016/j.cjca.2017.08.022.433.
  9. Gessert S., Kühl M. The multiple phases and faces of Wnt signaling during cardiac differentiation and development. Circ. Res., 2010, Vol. 107, pp. 186-199.
  10. Koval A., Purvanov V., Egger Adam D., Katanaev V.L. Yellow submarine of the WNT/Frizzled signaling: submerging from the G protein harbor to the targets. Biochem. Pharmacol., 2011, Vol. 82, pp. 1311-1319.
  11. Krishnamurthy N., Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. Cancer Treat Rev., 2017, Vol. 62, pp. 50-60.
  12. Meyer I.S., Jungmann A., Dieterich C., Zhang M., Lasitschka F., Werkmeister S., Haas J., Müller O.J., Boutros M., Nahrendorf M., Katus H.A., Hardt S.E., Leuschner F. The cardiac microenvironment uses noncanonical WNT signaling to activate monocytes after myocardial infarction. EMBO Mol. Med., 2017, Vol. 9, no. 9, pp. 1279-1293.
  13. Moon J., Zhou H., Zhang L.S., Tan W., Liu Y., Zhang S., Morlock L.K., Bao X., Palecek S.P., Feng J.Q., Williams N.S., Amatruda, J.F., Olson E.N., Bassel-Duby R., Lum L. Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist. Proc. Natl. Acad. Sci. USA, 2017, Vol. 114, pp. 1649-1654.
  14. Ozhan G., Weidinger G. Wnt/β-catenin signaling in heart regeneration. Cell Regen. (Lond.), 2015, Vol. 4, no. 1, 3. doi: 10.1186/s13619-015-0017-8.
  15. Yang D., Fu W., Li L., Xia X., Liao Q., Yue R., Chen H., Chen X., An S., Zeng C., Wang W.E. Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction. Clin. Sci., 2017, Vol. 131, pp. 2919-2932.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Plotnikova M.O., Snimshchikova I.A., Afoninа I.A., Kulakova A.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies